Vitro, S.A.B. de C.V.
VITOF
$0.15
-$0.51-77.27%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 70.91M | 72.11M | 70.00M | 71.00M | 79.16M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 70.91M | 72.11M | 70.00M | 71.00M | 79.16M |
| Cost of Revenue | 43.16M | 42.16M | 42.00M | 38.00M | 42.62M |
| Gross Profit | 27.75M | 29.95M | 28.00M | 33.00M | 36.54M |
| SG&A Expenses | 40.26M | 24.99M | 25.00M | 26.00M | 30.64M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -760.00K | -1.16M | 3.00M | -- | 1.31M |
| Total Operating Expenses | 82.67M | 65.99M | 70.00M | 64.00M | 74.56M |
| Operating Income | -11.75M | 6.12M | 0.00 | 7.00M | 4.60M |
| Income Before Tax | -34.53M | -36.03M | -67.00M | 25.00M | 28.58M |
| Income Tax Expenses | 594.00K | -1.57M | -14.00M | -1.00M | 9.72M |
| Earnings from Continuing Operations | -35.13M | -34.46M | -53.00M | 26.00M | 18.86M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | 23.67M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -35.13M | -34.46M | -53.00M | 26.00M | 42.29M |
| EBIT | -11.75M | 6.12M | 0.00 | 7.00M | 4.60M |
| EBITDA | -10.83M | 9.93M | 3.26M | 10.59M | 5.95M |
| EPS Basic | -0.07 | -0.07 | -0.11 | 0.06 | 0.09 |
| Normalized Basic EPS | -0.04 | -0.05 | -- | -- | 0.03 |
| EPS Diluted | -0.07 | -0.07 | -0.11 | 0.06 | 0.09 |
| Normalized Diluted EPS | -0.04 | -0.05 | -- | -- | 0.03 |
| Average Basic Shares Outstanding | 501.79M | 492.26M | 470.03M | 470.03M | 470.03M |
| Average Diluted Shares Outstanding | 501.79M | 492.26M | 470.03M | 470.03M | 470.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | 23.28% |